It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
The Italian National Health Service is founded on universal coverage and equal access to care.1 In this context, ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback